← Back to Search

Carbon Dioxide Challenge for Brain Blood Flow

N/A
Waitlist Available
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No psychiatric history, as defined by seeing a psychiatrist for medical evaluation and treatment, or taking anti-depressant medications
Not on vasodilatory medication, such as sildenafil or verapamil
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the beginning of the mri scan to the completion of the mri scan -- 75 minutes.
Awards & highlights

Study Summary

This trial will study how well the brain's blood vessels respond to breathing in carbon dioxide in patients with and without diseases that are known to cause problems with blood flow.

Who is the study for?
This trial is for healthy adults over 18 or those with brain vascular issues, without a history of seizures, psychiatric conditions, or on certain medications like vasodilators. Participants must be able to undergo an MRI without sedation and not require daily headache prevention meds.Check my eligibility
What is being tested?
The study tests how the brain's blood vessels respond to different levels of carbon dioxide and oxygen using a special mask during MRI imaging. It aims to understand blood flow and metabolism changes in normal individuals versus patients with disease.See study design
What are the potential side effects?
While not explicitly listed, potential side effects may include discomfort from wearing the mask, dizziness or lightheadedness due to changes in breathing gases, and typical MRI-related concerns such as claustrophobia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have not seen a psychiatrist nor taken antidepressants.
Select...
I am not taking any medication that widens my blood vessels.
Select...
I have never had a seizure.
Select...
I can undergo an MRI scan without needing to be sedated.
Select...
I am not taking any stimulant medications.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the beginning of the mri scan to the completion of the mri scan -- 75 minutes.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from the beginning of the mri scan to the completion of the mri scan -- 75 minutes. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cerebral Oxygen Metabolism
Secondary outcome measures
Cerebrovascular Reactivity

Trial Design

2Treatment groups
Active Control
Group I: Healthy AdultsActive Control1 Intervention
Group II: Adults diagnosed with vascular pathology of the brainActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,933 Previous Clinical Trials
2,299,677 Total Patients Enrolled

Media Library

Carbon Dioxide Clinical Trial Eligibility Overview. Trial Name: NCT04258774 — N/A
Hypocapnia Research Study Groups: Healthy Adults, Adults diagnosed with vascular pathology of the brain
Hypocapnia Clinical Trial 2023: Carbon Dioxide Highlights & Side Effects. Trial Name: NCT04258774 — N/A
Carbon Dioxide 2023 Treatment Timeline for Medical Study. Trial Name: NCT04258774 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still spots open for people who want to participate in this clinical trial?

"No, this trial is not currently looking for patients. The most recent update on clinicaltrials.gov was on October 7th, 2021 and the study was first posted on January 29th, 2020. That being said, there are 214 other studies that are actively recruiting right now."

Answered by AI
~22 spots leftby Dec 2027